Skip to main content

Table 12 Model results when frequency and duration of relapses are decreased by 10%

From: Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: A cost effectiveness study

 

Paliperidone ER

Olanzapine

Risperidone

Quetiapine

Ziprasidone

Aripiprazole

-10% in frequency of relapses:

Cost (€)

6.716

6.767

6.695

7.964

7.442

7.355

Effectiveness

281.7

281.4

275.5

271.1

269.2

271.0

ICER (€/stable day)

-

-

3,39

-

-

-

-10% in duration of relapses:

Cost (€)

6.801

6.852

6.786

8.060

7.539

7.451

Effectiveness

281.7

281.4

275.5

271.1

269.2

271.0

ICER (€/stable day)

-

-

2.42

-

-

-

  1. ICER, incremental cost effectiveness ratio.